PLSE — PULSE BIOSCIENCES, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1625101 ·
Last close
$49.98
Market Cap
$3.56B
52W High
$58.90
52W Low
$12.56
ADV30
618,433
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 434,000 | 161,000 | -25,272,000 | -24,657,000 | 115,564,000 | 101,620,000 | 16,064,000 |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 264,000 | 4,000 | -18,253,000 | -17,433,000 | 94,539,000 | 80,735,000 | 13,883,000 |
| Sep 2025 | 86,000 | -193,000 | -20,367,000 | -19,385,000 | 108,765,000 | 95,214,000 | 16,071,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-61,098,000
Investing CF
$-290,000
Financing CF
$56,659,000
CapEx
$-290,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.18
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-506,519,000
Inventory
$236,000
Receivables
$122,000
ST Investments
—
EBIT TTM
$-83,042,000
Pretax Income TTM
$-80,056,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,185,000
EBITDA
$-82,618,000
Free Cash Flow
$-34,285,248
Enterprise Value
$3,693,095,680
Total Cash
$101,620,000
Total Debt
$6,772,000
Shares Out
71,322,607
Trailing EPS
$-1.17
Book Value
$1.41
ROE
-78.5%
ROA
-44.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 350,000 | -76,939,000 | -72,781,000 | 94,539,000 | 13,883,000 | 80,656,000 | -54,122,000 |
| Dec 2024 | 0 | -56,257,000 | -53,585,000 | 132,460,000 | 17,598,000 | 114,862,000 | -36,343,000 |
| Dec 2023 | 0 | -43,574,000 | -42,210,000 | 59,154,000 | 14,794,000 | 44,360,000 | -33,041,000 |
| Dec 2022 | 700,000 | -58,057,000 | -58,505,000 | 77,877,000 | 80,125,000 | -2,248,000 | -47,013,000 |
TTM Snapshot
Revenues TTM
$751,000
NetIncome TTM
$-74,567,000
OpCashFlow TTM
—
Assets (Latest)
$81,622,000
Forward EPS
$-1.15
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $32.00 · spot: $53.81 · call volume: 88 · put volume: 16
Expected Move to 2026-10-16:
±$5.58
(10.36%) —
implied range
$48.24 –
$59.39
· ATM straddle on $55.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NVST | Envista Holdings Corp | $3.65B | $22.72 | — |
| IRTC | iRhythm Holdings, Inc. | $3.38B | $102.60 | — |
| ICUI | ICU MEDICAL INC/DE | $3.93B | $157.18 | — |
| HTFL | Heartflow, Inc. | $4.14B | $47.63 | — |
| LIVN | LivaNova PLC | $4.17B | $75.91 | — |
News headlines (Yahoo Finance, 1h cache)
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-09 20:05 · Yahoo
Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026
2026-10-08 11:00 · Yahoo
Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment
2026-10-07 11:00 · Yahoo
Pulse Biosciences (PLSE) Stock Fair Value Rises After Analysts Back NsPFA Data
2026-10-03 19:07 · Yahoo
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
2026-09-15 11:00 · Yahoo
Why Pulse Biosciences Stock Popped Today
2026-09-09 23:44 · Yahoo
Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform
2026-08-16 13:01 · Yahoo
Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript
2026-08-13 23:31 · Yahoo
Pulse Biosciences Q2 Earnings Call Highlights
2026-08-07 08:03 · Yahoo
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates
2026-08-06 23:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.